No More Cross-Border Information Asymmetry,
Every Cent of Life-Saving Money Is Spent Where It Matters.
YILV CHINA strictly upholds a neutral coordination principle. All medical treatment fees are paid directly to the designated national Grade 3 Class A public hospital in China, and the invoice, electronically supervised by the Ministry of Finance, is issued directly to the patient. Referral services are priced at fixed, publicly listed rates throughout the entire process, eliminating cross-border practices such as middlemen skimming margins or high commissions influencing prescriptions.
Drugs and medical consumables are charged at the published standard prices set by China's medical insurance pricing authority.
Patients pay the hospital's corporate account directly by dual-currency card or wire transfer; the platform retains no funds at any point.
Approx. RM 1,400 fixed fee. Covers record restructuring, written specialist review and submission/hospital coordination; the service ends once hospital coordination and appointment registration are complete. Full refund if not accepted for treatment.
"Fully Segregated Three-Stream Funds": An In-Depth Look at the Transparency Rule
No opaque bundled pricing. YILV CHINA breaks every cross-border medical expense down into three separate accounts and three types of verifiable evidence: public hospital receipts bearing the official seal, travel and accommodation billed at actual cost, and referral services at clearly listed prices. Every step supports corporate account verification and Takaful direct-billing audits.
Medical Treatment and Drug Costs
Paid direct to the official corporate finance account of a Chinese Grade 3 Class A public hospitalLiving, Travel and Companion Expenses
Booked only on genuine demand; flights and carer accommodation reimbursed at actual costCross-Border Professional Referral Fee
Fixed publicly listed charges; record restructuring, hospital coordination and specialist reviewService & fee boundaries
One table: what is free, what USD 300 covers, and what it does not- Receipt and completeness check of submitted materials
- No specialist opinion issued; not an admission decision
- No fee and no obligation of any kind
- Medical record collection, English-Chinese medical translation and clinical restructuring (including pathology and imaging material)
- Submission and hospital coordination in China: routing to the right department and specialist team, appointment and record registration
- Written specialist review opinion (admission feasibility and treatment pathway guidance)
- Full refund under the stated terms if the case offers no treatment value or no clinical benefit
- Companionship inside the hospital, airport transfers and ground handling
- Travel, accommodation, visa and health check-up costs
- All medical fees charged by the hospital (paid by the patient directly to the hospital)
End of service:Once hospital coordination, appointment and record registration are complete, the platform service ends. Subsequent treatment, admission, tests and in-hospital communication in China are handled by the receiving hospital team, and the platform charges no further fees.
Reference Cost Ranges for Critical Illness Treatment in China: China, Malaysia and Singapore Compared
Estimated from China's 2024 standard inpatient charging guidance prices at national Grade 3 Class A public hospitals, and the published median statistics of major private specialist centres in Kuala Lumpur (Gleneagles / Sunway) and private specialist centres in Singapore (Mount Elizabeth).
| Condition and Advanced Treatment | Official China Grade 3A Public Range | Malaysia Private Specialist Range | Singapore Private Healthcare Range | Self-Pay Savings in China |
|---|---|---|---|---|
CAR-T Cell ImmunotherapyRelapsed or refractory diffuse large B-cell lymphoma, leukaemia, multiple myeloma | ¥ 990,000 - ¥ 1,200,000Approx. RM 643,500 - RM 780,000Includes cell infusion, pre-conditioning chemotherapy and ICU observation | RM 1,500,000 - RM 1,900,000Requires special import approval; waiting period about 6-10 weeks | SGD 550,000 - SGD 700,000Approx. RM 1,925,000+ | Save 58% - 65% |
Proton and Heavy Ion Radiotherapy (PT/HIRT)Skull base chordoma, locally recurrent nasopharyngeal carcinoma, paediatric central nervous system tumours, advanced liver cancer | ¥ 278,000 - ¥ 310,000Approx. RM 180,700 - RM 201,500All-inclusive price for one course of treatment (about 20-35 sessions) | No commercial proton or heavy ion facility availableMost Malaysian patients are referred overseas as self-paying patients | SGD 90,000 - SGD 130,000Approx. RM 315,000 - RM 455,000 | 48% - 56% Less Than Singapore |
Complex Neurosurgery and Minimally Invasive Brainstem/Skull Base Tumour SurgeryTiantan/Huashan-grade intraoperative MRI (iMRI) plus neuronavigated craniotomy | ¥ 120,000 - ¥ 180,000Approx. RM 78,000 - RM 117,000Includes preoperative functional mapping, intraoperative electrophysiological monitoring and 3 days of standard ICU care | RM 160,000 - RM 250,000Advanced consumables such as artificial dura and titanium cranial mesh are charged separately | SGD 75,000 - SGD 110,000Approx. RM 262,500 - RM 385,000 | Save 52% - 70% |
Da Vinci Xi Robotic Complex Organ ResectionPancreaticoduodenectomy (Whipple), radical prostatectomy, sphincter-preserving surgery for low rectal cancer | ¥ 90,000 - ¥ 140,000Approx. RM 58,500 - RM 91,000Includes robotic arm start-up consumables, hospital stay and perioperative care | RM 120,000 - RM 190,000Only a few leading private hospitals in Kuala Lumpur and Penang have the system | SGD 60,000 - SGD 90,000Approx. RM 210,000 - RM 315,000 | Save 51% - 71% |
Allogeneic Haematopoietic Stem Cell Transplant (BMT)Leukaemia and severe aplastic anaemia (Beijing haploidentical transplantation protocol) | ¥ 350,000 - ¥ 550,000Approx. RM 227,500 - RM 357,500Includes admission to a Class 100 laminar flow unit, donor mobilisation and graft-versus-host disease management | RM 450,000 - RM 700,000Waiting for a fully matched donor from the bone marrow registry usually takes months | SGD 180,000 - SGD 260,000Approx. RM 630,000 - RM 910,000 | Save 49% - 61% |
Full Treatment Budget Estimate and Official Invoice Documentation
Before travelling to China, you will receive a "Personalised Single-Condition Budget Approval Statement" bearing the YILV CHINA Malaysia-China cross-border specialist collaboration seal. On discharge, you will receive formal medical fee vouchers administered by China's national tax and finance authorities, meeting the standards for Malaysian insurance claims and overseas income tax deductions.
Pre-Travel Cross-Border Treatment Cost Estimate
China Public Hospital Machine-Printed Electronic Outpatient/Inpatient Receipt
Claim support for Malaysian insurers (Takaful / AIA / Great Eastern):
Frequently Asked Financial Questions About Treatment in China (FAQ)
Removing concerns about cross-border transfers, so every payment is documented, lawful and compliant.
Get Your Personalised
Budget List for Treatment at a Chinese Grade 3A Public Hospital
Share your current diagnosis and a summary of your latest pathology report, and within 24 hours the YILV CHINA cross-border coordination team will check national public pricing databases and prepare a transparent estimate covering surgery, hospital stay, advanced new therapies and travel.
